eHealthMe - FDA and Social Media, Personalized eHealthMe - a cloud computing service for drugs

FDA and Social Media, Personalized

Advanced tools
Browse eHealthMe       Feature support groups

From FDA reports: drug interactions between Cipro, Levaquin, Valium, Baclofen for a Female patient aged 69

This is a personalized study for a 69 year old female patient. The study is created by eHealthMe based on reports of 7 people who take the same drugs and have drug interactionsfrom FDA.

On Jul, 24, 2014: 7 people who reported to have interactions when taking Cipro, Levaquin, Valium, Baclofen are studied

Trend of Cipro, Levaquin, Valium, Baclofen's drug interactions, side effects, and effectiveness reports (926265)

Information of the patient in this study:

Age: 69

Gender: female

Conditions: Respiratory Disorder

Drugs taking:
- Cipro
- Levaquin
- Valium
- Baclofen

Drug interactions have: Cardio-respiratory Arrest, Hypotension, Refusal Of Treatment By Patient, Respiratory Distress, Respiratory Failure, Ventricular Fibrillation, Ventricular Tachycardia

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 69 (±5):

InteractionNumber of reports
Cardio-respiratory Arrest (sudden dysfunction of heart and lungs)5 (100.00%)
Hypotension (abnormally low blood pressure)5 (100.00%)
Refusal Of Treatment By Patient5 (100.00%)
Respiratory Distress (difficulty in breathing)5 (100.00%)
Respiratory Failure (inadequate gas exchange by the respiratory system)5 (100.00%)
Ventricular Fibrillation (abnormally irregular heart rhythm)5 (100.00%)
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)5 (100.00%)

Most common interactions experienced by females aged 69 (±5) in the use of Cipro, Levaquin, Valium, Baclofen:

InteractionNumber of reports
Respiratory Failure (inadequate gas exchange by the respiratory system)5
Ventricular Fibrillation (abnormally irregular heart rhythm)5
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)5
Respiratory Distress (difficulty in breathing)5
Hypotension (abnormally low blood pressure)5
Cardio-respiratory Arrest (sudden dysfunction of heart and lungs)5
Depressed Level Of Consciousness5
Apnoea (suspension of external breathing)5
Blood Ph Decreased5
Tachypnoea (condition of rapid breathing over 20 per minute)5

Most common interactions experienced by females aged 69 (±5) in long term use of Cipro, Levaquin, Valium, Baclofen:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Cardio-respiratory Arrest (sudden dysfunction of heart and lungs)7 (100.00%)
Hypotension (abnormally low blood pressure)7 (100.00%)
Refusal Of Treatment By Patient6 (85.71%)
Respiratory Distress (difficulty in breathing)7 (100.00%)
Respiratory Failure (inadequate gas exchange by the respiratory system)7 (100.00%)
Ventricular Fibrillation (abnormally irregular heart rhythm)7 (100.00%)
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)7 (100.00%)

Most common interactions experienced by people in the use of Cipro, Levaquin, Valium, Baclofen:

InteractionNumber of reports
Respiratory Failure (inadequate gas exchange by the respiratory system)7
Dyspnoea (difficult or laboured respiration)7
Respiratory Distress (difficulty in breathing)7
Ventricular Fibrillation (abnormally irregular heart rhythm)7
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)7
Hypotension (abnormally low blood pressure)7
Apnoea (suspension of external breathing)7
Rhonchi (abnormal breath sounds)7
Tachypnoea (condition of rapid breathing over 20 per minute)7
Blood Ph Decreased7

Most common interactions experienced by people in long term use of Cipro, Levaquin, Valium, Baclofen:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.